Literature DB >> 29916852

Epithelial sodium channel biogenesis and quality control in the early secretory pathway.

Teresa M Buck1, Jeffrey L Brodsky.   

Abstract

PURPOSE OF REVIEW: The epithelial sodium channel, ENaC, is responsible for Na reabsorption in several epithelia and is composed of homologous α, β, and γ subunits. Here, we will explore the differential regulation of ENaC subunits during biogenesis in the early secretory pathway. RECENT
FINDINGS: ENaC subunits are subject to numerous posttranslational modifications, including glycosylation, protease activation, disulfide bond formation, palmitoylation, and glycosylation, each of which modulate channel function. For example, glycan addition is regulated by sodium and affects protease activation at the cell surface, protein trafficking, sodium-dependent regulation, and sodium transport. Glycosylation of the α subunit also determines whether a chaperone, Lhs1/GRP170, selects the protein for endoplasmic reticulum-associated degradation. Recognition by this chaperone is blocked by assembly of the ENaC transmembrane domains. In contrast, cytosolic lysines are acetylated in the early secretory pathway, which inhibits ubiquitination and endocytosis at the cell surface.
SUMMARY: As sodium reabsorption by ENaC in the distal nephron regulates salt and water homeostasis, ENaC function is critical for human health. Therefore, identifying and characterizing modifiers of ENaC in the early secretory pathway may provide both new therapeutic targets and further our basic understanding of membrane protein assembly and regulation.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29916852     DOI: 10.1097/MNH.0000000000000438

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  8 in total

1.  Paraoxonase 3 functions as a chaperone to decrease functional expression of the epithelial sodium channel.

Authors:  Shujie Shi; Nicolas Montalbetti; Xueqi Wang; Brittney M Rush; Allison L Marciszyn; Catherine J Baty; Roderick J Tan; Marcelo D Carattino; Thomas R Kleyman
Journal:  J Biol Chem       Date:  2020-02-20       Impact factor: 5.157

2.  Paraoxonase 2 is an ER chaperone that regulates the epithelial Na+ channel.

Authors:  Shujie Shi; Teresa M Buck; Andrew J Nickerson; Jeffrey L Brodsky; Thomas R Kleyman
Journal:  Am J Physiol Cell Physiol       Date:  2021-12-01       Impact factor: 4.249

Review 3.  PTEN: An Emerging Potential Target for Therapeutic Intervention in Respiratory Diseases.

Authors:  Bangrong Cai; Liu Yang; Young Do Jung; Ying Zhang; Xinguang Liu; Peng Zhao; Jiansheng Li
Journal:  Oxid Med Cell Longev       Date:  2022-06-30       Impact factor: 7.310

4.  Ubiquitination of renal ENaC subunits in vivo.

Authors:  Gustavo Frindt; Marko Bertog; Christoph Korbmacher; Lawrence G Palmer
Journal:  Am J Physiol Renal Physiol       Date:  2020-03-16

5.  Estrogen negatively regulates the renal epithelial sodium channel (ENaC) by promoting Derlin-1 expression and AMPK activation.

Authors:  Xue Zhang; Yamei Ge; Ashfaq-Ahmad-Shah Bukhari; Qian Zhu; Yachen Shen; Min Li; Hui Sun; Dongming Su; Xiubin Liang
Journal:  Exp Mol Med       Date:  2019-05-21       Impact factor: 8.718

Review 6.  Protein quality control in the secretory pathway.

Authors:  Zhihao Sun; Jeffrey L Brodsky
Journal:  J Cell Biol       Date:  2019-09-19       Impact factor: 10.539

7.  Bone marrow mesenchymal stem cells derived miRNA-130b enhances epithelial sodium channel by targeting PTEN.

Authors:  Honglei Zhang; Yan Ding; Yapeng Hou; Yanhong Liu; Zhiyu Zhou; Hongguang Nie
Journal:  Respir Res       Date:  2020-12-11

8.  The molecular chaperone GRP170 protects against ER stress and acute kidney injury in mice.

Authors:  Aidan W Porter; Diep N Nguyen; Dennis R Clayton; Wily G Ruiz; Stephanie M Mutchler; Evan C Ray; Allison L Marciszyn; Lubika J Nkashama; Arohan R Subramanya; Sebastien Gingras; Thomas R Kleyman; Gerard Apodaca; Linda M Hendershot; Jeffrey L Brodsky; Teresa M Buck
Journal:  JCI Insight       Date:  2022-03-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.